Clay Siegall is the founder of Seattle Genetics and he has a long history as a founder of the company. The company is working on radical therapies for cancers which are a direct result of his research in an academic laboratory. Dr. Siegall has built worldwide collaborations with the benefit of his technology company, as many other individuals have seen the benefit of the company’s products and services for their own companies. The portfolio of preclinical/clinical products which Seattle Genetics makes available to their customers is nothing short of amazing.
The company Seattle Genetics is a pioneer in using antibody conjugates to treat lymphoma patients. It has the ability to prevent tumors from becoming malignant. Many collaborations with industry have been quite profitable, producing over $65 million in profits since 2001 which has enabled the company to expand their product line. Their therapies have the potential to treat many different malignant tumors and they have had licensing agreements approved in order for many of the other applications to be considered.
These antibody-based therapies for cancer have been considered to be one of the top biotechnology innovations. Globally, one of their therapies has been able to successfully cure thousands of patients around the world. Some patients are at a high risk for a relapse, so the therapies have been created in order to prevent that from happening. In either case, the company’s pipeline is diverse and designed to be great options for treating individuals whom have been afflicted with cancer and other serious illnesses.
With all of these great accomplishments, Clay Siegall has had a successful career without a doubt. He began as a professor and holds a Ph.D degree. From there, he has expanded on to the private sector and worked for many biotechnology companies. As an accomplished individual, he also provides mentorship and guidance to many students whom are looking to break into the biotech world. He also serves on the board of directors of many other biotechnology companies such as Alder BioPharmaceuticals, Mirna Therapeutics, and has even worked at the national institutes of health.